PlainRecalls
FDA Devices Critical Class I Terminated

EBI Osteogen Implantable Bone Growth Stimulator The OsteoGen Implantable Bone Growth Stimulator is indicated in the treatment of long bone nonunions.

Reported: November 7, 2018 Initiated: February 19, 2018 #Z-0286-2019

Product Description

EBI Osteogen Implantable Bone Growth Stimulator The OsteoGen Implantable Bone Growth Stimulator is indicated in the treatment of long bone nonunions.

Reason for Recall

Lack of adequate validation and controls to ensure that product cleanliness parameters were consistently met.

Details

Recalling Firm
Zimmer Biomet, Inc.
Units Affected
4,879 units (2,982 units have been implanted and 537 have been scrapped)
Distribution
US Nationwide Distribution: AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, VT, WA, WI, and WV ; and country of: Australia.
Location
Warsaw, IN

Frequently Asked Questions

What product was recalled?
EBI Osteogen Implantable Bone Growth Stimulator The OsteoGen Implantable Bone Growth Stimulator is indicated in the treatment of long bone nonunions.. Recalled by Zimmer Biomet, Inc.. Units affected: 4,879 units (2,982 units have been implanted and 537 have been scrapped).
Why was this product recalled?
Lack of adequate validation and controls to ensure that product cleanliness parameters were consistently met.
Which agency issued this recall?
This recall was issued by the FDA Devices on November 7, 2018. Severity: Critical. Recall number: Z-0286-2019.